AF
BSX icon

Avanza Fonder’s Boston Scientific BSX Stock Holding History

Avanza Fonder’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.65M Buy
179,197
+4,961
+3% +$269K 0.17% 114
2026
Q1 		$10.9M Sell
174,236
-8,743
-5% -$699K 0.3% 65
2025
Q4 		$17.4M Buy
182,979
+21,210
+13% +$2.08M 0.44% 41
2025
Q3 		$15.8M Buy
161,769
+3,676
+2% +$381K 0.41% 36
2025
Q2 		$17M Buy
158,093
+11,646
+8% +$1.18M 0.5% 29
2025
Q1 		$14.7M Sell
146,447
-14,924
-9% -$1.5M 0.48% 30
2024
Q4 		$14.4M Buy
+161,371
New +$14.2M 0.43% 37

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Avanza Fonder's BSX Position: Q2 2026 in Review

Avanza Fonder increased its Boston Scientific (BSX) stake by 2.8% in Q2 2026, buying an estimated $269K and bringing the position to 179,197 shares worth $7.65M. The position accounts for 0.17% of the portfolio, ranked #114.

Avanza Fonder first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $17.4M in Q4 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Avanza Fonder held 179,197 shares of Boston Scientific worth $7.65M as of Q2 2026.
  • Avanza Fonder bought 4,961 Boston Scientific shares in Q2 2026, an estimated $269K.
  • Boston Scientific made up 0.17% of Avanza Fonder's portfolio in Q2 2026, its #114 holding.
  • Avanza Fonder first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Avanza Fonder's Boston Scientific position peaked at $17.4M in Q4 2025.
  • 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.